drugset / Trial / NCT00846612
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer
Phase 1
Completed
15 enrolled
NYU Langone Health
Genentech, Inc. · collabUniversity of New Mexico Cancer Center · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is to study pharmacokinetics of Doxil using Doxil and Avastin on ovarian cancer patients who are resistant to or have relapsed from platinum-based therapy.
Timeline
- Start
- 2008-01
- Primary completion
- 2010-09
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 15 mg/kg | Intravenous |
| Subject | Doxorubicin | Other / unclassified | 30 mg/m2 | Intravenous |